| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | BCL6B ZNF845 ZNF573 ZNF547 ZBTB39 ZNF337 ZNF596 ZNF256 ZNF566 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZNF415 ZKSCAN5 ZNF840P ZNF563 | 4.02e-07 | 1412 | 59 | 17 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | BCL6B ZNF845 ZNF573 ZNF547 ZBTB39 ZNF337 ZNF596 ZNF256 ZNF566 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZNF415 ZKSCAN5 ZNF840P ZNF563 | 6.38e-07 | 1459 | 59 | 17 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | BCL6B ZNF845 ZNF573 ZNF547 ZBTB39 ZNF256 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZNF415 ZKSCAN5 ZNF840P | 5.49e-05 | 1244 | 59 | 13 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | BCL6B ZNF845 ZNF573 ZNF547 ZBTB39 ZNF256 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZNF415 ZKSCAN5 ZNF840P | 6.84e-05 | 1271 | 59 | 13 | GO:0000987 |
| HumanPheno | Steroetypic movements of face and head | 1.40e-05 | 63 | 13 | 4 | HP:5200017 | |
| MousePheno | decreased susceptibility to Togaviridae infection induced morbidity/mortality | 5.08e-06 | 2 | 32 | 2 | MP:0031041 | |
| MousePheno | decreased susceptibility to Togaviridae infection | 3.04e-05 | 4 | 32 | 2 | MP:0020941 | |
| MousePheno | abnormal susceptibility to Togaviridae infection | 1.06e-04 | 7 | 32 | 2 | MP:0020939 | |
| Domain | KRAB | ZNF845 ZNF573 ZNF547 ZNF337 ZNF596 ZNF256 ZNF566 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZKSCAN5 ZNF563 | 4.34e-11 | 358 | 57 | 13 | PS50805 |
| Domain | KRAB | ZNF845 ZNF573 ZNF547 ZNF337 ZNF596 ZNF256 ZNF566 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZKSCAN5 ZNF563 | 4.34e-11 | 358 | 57 | 13 | PF01352 |
| Domain | KRAB | ZNF845 ZNF573 ZNF547 ZNF337 ZNF596 ZNF256 ZNF566 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZKSCAN5 ZNF563 | 6.32e-11 | 369 | 57 | 13 | SM00349 |
| Domain | KRAB | ZNF845 ZNF573 ZNF547 ZNF337 ZNF596 ZNF256 ZNF566 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZKSCAN5 ZNF563 | 6.54e-11 | 370 | 57 | 13 | IPR001909 |
| Domain | ZINC_FINGER_C2H2_2 | BCL6B ZNF845 ZNF573 ZNF547 ZBTB39 ZNF337 ZNF596 ZNF256 ZNF566 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZNF804A ZNF415 ZKSCAN5 ZNF563 | 7.92e-11 | 775 | 57 | 17 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | BCL6B ZNF845 ZNF573 ZNF547 ZBTB39 ZNF337 ZNF596 ZNF256 ZNF566 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZNF804A ZNF415 ZKSCAN5 ZNF563 | 8.25e-11 | 777 | 57 | 17 | PS00028 |
| Domain | - | BCL6B ZNF845 ZNF573 ZNF547 ZBTB39 ZNF337 ZNF596 ZNF256 ZNF566 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZNF415 ZKSCAN5 ZNF563 | 1.13e-10 | 679 | 57 | 16 | 3.30.160.60 |
| Domain | Znf_C2H2-like | BCL6B ZNF845 ZNF573 ZNF547 ZBTB39 ZNF337 ZNF596 ZNF256 ZNF566 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZNF804A ZNF415 ZKSCAN5 ZNF563 | 1.20e-10 | 796 | 57 | 17 | IPR015880 |
| Domain | Znf_C2H2 | BCL6B ZNF845 ZNF573 ZNF547 ZBTB39 ZNF337 ZNF596 ZNF256 ZNF566 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZNF804A ZNF415 ZKSCAN5 ZNF563 | 1.43e-10 | 805 | 57 | 17 | IPR007087 |
| Domain | ZnF_C2H2 | BCL6B ZNF845 ZNF573 ZNF547 ZBTB39 ZNF337 ZNF596 ZNF256 ZNF566 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZNF804A ZNF415 ZKSCAN5 ZNF563 | 1.51e-10 | 808 | 57 | 17 | SM00355 |
| Domain | zf-C2H2 | BCL6B ZNF845 ZNF573 ZNF547 ZBTB39 ZNF337 ZNF596 ZNF256 ZNF566 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZNF415 ZKSCAN5 ZNF563 | 1.52e-10 | 693 | 57 | 16 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | BCL6B ZNF845 ZNF573 ZNF547 ZBTB39 ZNF337 ZNF596 ZNF256 ZNF566 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZNF415 ZKSCAN5 ZNF563 | 1.56e-10 | 694 | 57 | 16 | IPR013087 |
| Domain | zf-C2H2_6 | 4.71e-06 | 314 | 57 | 8 | PF13912 | |
| Domain | C-RASSF | 1.36e-04 | 6 | 57 | 2 | IPR033614 | |
| Domain | Nore1-SARAH | 1.36e-04 | 6 | 57 | 2 | PF16517 | |
| Domain | SARAH | 3.25e-04 | 9 | 57 | 2 | PS50951 | |
| Domain | SARAH_dom | 3.25e-04 | 9 | 57 | 2 | IPR011524 | |
| Domain | BTB | 6.85e-04 | 131 | 57 | 4 | PF00651 | |
| Domain | BTB | 1.44e-03 | 160 | 57 | 4 | PS50097 | |
| Domain | RHO | 1.68e-03 | 20 | 57 | 2 | PS51420 | |
| Domain | BTB | 2.21e-03 | 180 | 57 | 4 | SM00225 | |
| Domain | BTB/POZ_dom | 2.44e-03 | 185 | 57 | 4 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 2.64e-03 | 189 | 57 | 4 | IPR011333 | |
| Domain | RA | 4.02e-03 | 31 | 57 | 2 | SM00314 | |
| Domain | RA | 5.39e-03 | 36 | 57 | 2 | PF00788 | |
| Domain | RA | 5.69e-03 | 37 | 57 | 2 | PS50200 | |
| Domain | RA_dom | 6.63e-03 | 40 | 57 | 2 | IPR000159 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 24238405 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 20067833 | ||
| Pubmed | The Dictyostelium discoideum family of Rho-related proteins. | 8.77e-06 | 3 | 60 | 2 | 11222756 | |
| Pubmed | Atypical Rho GTPases of the RhoBTB Subfamily: Roles in Vesicle Trafficking and Tumorigenesis. | 8.77e-06 | 3 | 60 | 2 | 27314390 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 27339399 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 12426103 | ||
| Pubmed | 1.56e-05 | 181 | 60 | 5 | 37372979 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 20596075 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 23009887 | ||
| Pubmed | 2.22e-05 | 493 | 60 | 7 | 15368895 | ||
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 18835386 | ||
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 24659690 | ||
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 22709582 | ||
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 16357940 | ||
| Pubmed | 6.11e-05 | 7 | 60 | 2 | 19066393 | ||
| Pubmed | Placental ATPase expression is a link between multiple causes of spontaneous abortion in mice. | 8.14e-05 | 8 | 60 | 2 | 21593477 | |
| Pubmed | 8.14e-05 | 8 | 60 | 2 | 24923387 | ||
| Pubmed | 8.14e-05 | 8 | 60 | 2 | 22454532 | ||
| Pubmed | Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences. | 1.05e-04 | 9 | 60 | 2 | 20920251 | |
| Pubmed | IL12RB2 GTF2H1 ZNF316 ZKSCAN2 RERE INO80 KAT6B ZKSCAN5 UNC5D | 1.19e-04 | 1116 | 60 | 9 | 31753913 | |
| Pubmed | 1.91e-04 | 12 | 60 | 2 | 30061196 | ||
| Pubmed | 2.63e-04 | 14 | 60 | 2 | 18715339 | ||
| Pubmed | A human RNA polymerase II complex containing factors that modify chromatin structure. | 3.46e-04 | 16 | 60 | 2 | 9710619 | |
| Pubmed | Dragon (repulsive guidance molecule b) inhibits IL-6 expression in macrophages. | 4.91e-04 | 19 | 60 | 2 | 21187450 | |
| Pubmed | 7.85e-04 | 104 | 60 | 3 | 9205841 | ||
| Pubmed | 9.99e-04 | 27 | 60 | 2 | 19604093 | ||
| Pubmed | Generation of functional multipotent adult stem cells from GPR125+ germline progenitors. | 1.23e-03 | 30 | 60 | 2 | 17882221 | |
| Pubmed | 1.58e-03 | 34 | 60 | 2 | 24026423 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 2.34e-05 | 1192 | 60 | 9 | chr19q13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | BCL6B ZNF845 ZNF573 ZNF547 ZBTB39 ZNF337 ZNF596 ZNF256 ZNF566 ZNF316 ZNF616 ZKSCAN2 ZNF699 ZNF415 ZKSCAN5 ZNF563 | 1.54e-11 | 718 | 47 | 16 | 28 |
| GeneFamily | Ras association domain family | 2.94e-04 | 10 | 47 | 2 | 1198 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 4.02e-04 | 134 | 47 | 4 | 861 | |
| GeneFamily | Rho family GTPases | 1.22e-03 | 20 | 47 | 2 | 390 | |
| ToppCell | Adult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor | 5.44e-06 | 191 | 59 | 5 | cbebb4d9550fdcd606cb3685ac9546c6b73fd422 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.64e-06 | 199 | 59 | 5 | 744b63fba33b176ab7dde11646ccb313665505f7 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Follicular-6|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.10e-05 | 135 | 59 | 4 | 8197d49e697a1fdcd64040ea7a7f0b3ad0a756eb | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-iNKT-MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.81e-05 | 151 | 59 | 4 | 7e5e35ce601ca3d3722063566e89664909171b8d | |
| ToppCell | normal_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 6.94e-05 | 166 | 59 | 4 | 07b498eb341abec02a3ccaae320bdbb5cd6883c5 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-05 | 169 | 59 | 4 | 2d3618f78484bd3508b7bdae3a0d0183cdae5057 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 170 | 59 | 4 | f08aa6168ff0c20b2083dbf588dd3294e3d9580e | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.97e-05 | 172 | 59 | 4 | dd3a23dc78dc6939f41126f8d7bd23a2e4713647 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-05 | 172 | 59 | 4 | 72fbfa890995e47048b47199c170cc7dcd7661f8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-05 | 172 | 59 | 4 | 2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.97e-05 | 172 | 59 | 4 | 04fabb40fa9357d8902f3b04adc15231626cd9f8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Neutrophil|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.15e-05 | 173 | 59 | 4 | dfa56753319c92ae5b337793c4d6d5f70afce546 | |
| ToppCell | facs-Heart-RV-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-05 | 175 | 59 | 4 | bde002379088c0407afd0f3dae60b6a166683957 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.52e-05 | 175 | 59 | 4 | 0c6cf88818037bef67211c1a8fcb1e7d47711c1d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Neutrophil|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.90e-05 | 177 | 59 | 4 | ed44b1bf2ffae97f94e944d1b6060d5163eba6a6 | |
| ToppCell | normal_Lung-Myeloid_cells-CD163+CD14+_DCs|normal_Lung / Location, Cell class and cell subclass | 9.10e-05 | 178 | 59 | 4 | b6dacaad09bf4384d0d4c926fbf769e74a8ec9a9 | |
| ToppCell | Bronchial_Biopsy-Immune-Neutrophils|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.29e-05 | 179 | 59 | 4 | 8c50e13927c09de05c86cd90dd6f71cee004b0d3 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.50e-05 | 180 | 59 | 4 | 97241f62ee133dcb0d4855ffda5dd1349de9f7b2 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.50e-05 | 180 | 59 | 4 | 41896546cd1cc458e08c0d4e19aa4860e5d4fcd6 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.91e-05 | 182 | 59 | 4 | c98da2db197b1531204e116600ff51891e5c17af | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.91e-05 | 182 | 59 | 4 | d5d6bc16458bc665e7ad6669040d79f73f640044 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.91e-05 | 182 | 59 | 4 | 0b59ead4bb4486c7ec2ee90b94ee3a09905612c5 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.01e-04 | 183 | 59 | 4 | 9840706f972387241bf1d4ba8af25efc3214a91b | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-Myeloid_Dendritic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.01e-04 | 183 | 59 | 4 | 409cb52cf4c967e52bf75a6680bcbe87f638c75d | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.06e-04 | 185 | 59 | 4 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 187 | 59 | 4 | d69f4eee0304a7db226275ab77fc9d5d2b6f3a07 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 188 | 59 | 4 | 4e27ada1bda88811b73376c8a6136cbfc83bfdb9 | |
| ToppCell | control-Myeloid-Resident_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.12e-04 | 188 | 59 | 4 | 9bcd6a83da912d136745d1abcb34b3735141048c | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 1.12e-04 | 188 | 59 | 4 | e83de94a9b47a6a90e98face887eae031a322af6 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.12e-04 | 188 | 59 | 4 | e239bcdbd210a398a5850cb6fbf171d402f45a4f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 189 | 59 | 4 | 7ccea2df93bb4b37417bbc8f6c85a61ece95211a | |
| ToppCell | NS-control-d_0-4-Myeloid-Resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.17e-04 | 190 | 59 | 4 | 5215d2a4ac0475c621f6e6c477916149e2f73d64 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.19e-04 | 191 | 59 | 4 | c383ae386bc53e73a683a9543c7dfed2a65257c5 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 192 | 59 | 4 | 62eac1b8aed4fb924946b58c0237313f697a0136 | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.22e-04 | 192 | 59 | 4 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.24e-04 | 193 | 59 | 4 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | wk_20-22-Hematologic-Myeloid-DC3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.24e-04 | 193 | 59 | 4 | 12d1e7ed0bcd1259d6dc8ae962aad69586e5d26b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 194 | 59 | 4 | badefcec2af86cbcd97305f4843e84db0f3ebc66 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-04 | 195 | 59 | 4 | 3a30479857fc2805df92655c9599389559b1995d | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.29e-04 | 195 | 59 | 4 | 0110b976f98561ecd2e20ff6e7e3960a401bb7c2 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-04 | 195 | 59 | 4 | 050fc59b328391d6e3ce23051764a842dcbb3144 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.32e-04 | 196 | 59 | 4 | f943519bff51c3094776fd45889dadf9062c8379 | |
| ToppCell | Bronchial_Biopsy-Immune-Dendritic_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.32e-04 | 196 | 59 | 4 | bd828596c5b3fd5e4156f555e532f3de99d32f92 | |
| ToppCell | Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.32e-04 | 196 | 59 | 4 | ab0a8f5f388c9794d7f41f99fb0a5f2fd6fff6b3 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.32e-04 | 196 | 59 | 4 | aa53ae1e5d08d31cfd81b7fae46c2b5d21d4f9b2 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.34e-04 | 197 | 59 | 4 | e567886d69c6ea8dec87019c2ebc593793cb3107 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.34e-04 | 197 | 59 | 4 | e3349a381723393cd255f202afedd0c99037939b | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-04 | 197 | 59 | 4 | e2983ae16c72371fbf0e5c123de9f4d900724e5e | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.34e-04 | 197 | 59 | 4 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-04 | 197 | 59 | 4 | d568354aff89ac84dd06360f19100ef578a041ed | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 197 | 59 | 4 | c34d0d11c5c6154988b41e00aea169090cb09785 | |
| ToppCell | mild_COVID-19-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.34e-04 | 197 | 59 | 4 | 5d826f4d7b7a46847c67e6bef38eb860bc808a6c | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_2|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-04 | 197 | 59 | 4 | febafd8f0f5bb9a09f496f240e6b6b5e9275669b | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.37e-04 | 198 | 59 | 4 | d347462ba6cb1c5a59c86dffbbe914cbc1e9cf16 | |
| ToppCell | Healthy-cDC|World / disease group, cell group and cell class | 1.37e-04 | 198 | 59 | 4 | 8976f8d26cb7ff79f74def138c4bbbb0bc2eaf00 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.37e-04 | 198 | 59 | 4 | 9aaff68107ae4542f904b142d23669f2fcd557ac | |
| ToppCell | medial-2-Hematologic-OLR1+_Classical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-04 | 198 | 59 | 4 | d0a63cb48deecfdb8902c9229e457b7678aff178 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.37e-04 | 198 | 59 | 4 | 4780f0276546962a2fc9f1041cfe49d2919d72b2 | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.37e-04 | 198 | 59 | 4 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.37e-04 | 198 | 59 | 4 | e1a0c809302a3b304775bd708201ad412a98d711 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.37e-04 | 198 | 59 | 4 | c5a22846bccff948f90bc1d5fe309907dcd08348 | |
| ToppCell | Bronchial_Biopsy-Immune|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.37e-04 | 198 | 59 | 4 | 1c30eebbe16a331039a9063b93774b5daf518b6e | |
| ToppCell | COVID-19_Mild-Myeloid-Classical_Monocyte|COVID-19_Mild / Disease group, lineage and cell class | 1.37e-04 | 198 | 59 | 4 | e78d027a095473af555762a4d542a73f5bb2e166 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 1.37e-04 | 198 | 59 | 4 | 6b956073898192b1c6c8da66416b6a9b20d28a82 | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 1.37e-04 | 198 | 59 | 4 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-04 | 198 | 59 | 4 | 623f9d64c9e800d2d7f623392bf2f22b563f0249 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.37e-04 | 198 | 59 | 4 | c49c71b34151d82b8795763bcb633c301c35f659 | |
| ToppCell | medial-Hematologic-OLR1+_Classical_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-04 | 198 | 59 | 4 | 74f79fd3b173c236e79b8b8f59a3b7c02ea082c6 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.37e-04 | 198 | 59 | 4 | 5aaf3861c53763cf09bb628c9d2eabb6a7277021 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-04 | 198 | 59 | 4 | c77421898cc84ae2e8cc335087198dd05f13bfa5 | |
| ToppCell | medial-Hematologic-OLR1+_Classical_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-04 | 198 | 59 | 4 | 3f21354eb3e5f0949aec21dc2a8940e70464ecc7 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.40e-04 | 199 | 59 | 4 | 96dfbcf5261286f17d9718b04ebb7b288d229b52 | |
| ToppCell | tumor_Lung-Myeloid_cells|tumor_Lung / Location, Cell class and cell subclass | 1.40e-04 | 199 | 59 | 4 | a15f7d85efa47245ec6bb398379da1eec9572b75 | |
| ToppCell | mLN-(4)_Monocyte|mLN / shred on region, Cell_type, and subtype | 1.40e-04 | 199 | 59 | 4 | 6795ff31f92580195c9db776951f99d647484d24 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.40e-04 | 199 | 59 | 4 | 60e6312a149e23e4b486d92fb1f9625960b69c9d | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.40e-04 | 199 | 59 | 4 | 80ed217d28ba1c07facd0e103c25a02658dd848d | |
| ToppCell | mLN-Monocyte|mLN / Region, Cell class and subclass | 1.40e-04 | 199 | 59 | 4 | 241f790cd5d8a9b2451333deecc826a673bae70a | |
| ToppCell | Caecum-Dendritic_cell-cDC2|Caecum / Region, Cell class and subclass | 1.40e-04 | 199 | 59 | 4 | 944c567307082dd54dc141e93965d46f4ec8bc1f | |
| ToppCell | Sigmoid-(5)_Dendritic_cell-(50)_cDC2|Sigmoid / shred on region, Cell_type, and subtype | 1.40e-04 | 199 | 59 | 4 | 402af84db90d8a49d67cf44c24766aefb00fd716 | |
| ToppCell | mLN-(4)_Monocyte-(40)_Monocyte|mLN / shred on region, Cell_type, and subtype | 1.40e-04 | 199 | 59 | 4 | bcbb1eee8d79bf670dbe113094c3a292b135ce2f | |
| ToppCell | Sigmoid-Dendritic_cell-cDC2|Sigmoid / Region, Cell class and subclass | 1.40e-04 | 199 | 59 | 4 | cd74db6db694b68f81dcf9d9342d125d00357ec1 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_activated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-04 | 199 | 59 | 4 | 82759af613ebfffe037afda55159bf6af812c3ac | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-04 | 199 | 59 | 4 | 87d513a521dd0359f4f79b01e9e97eacb0a3c6e2 | |
| ToppCell | Caecum-(5)_Dendritic_cell-(50)_cDC2|Caecum / shred on region, Cell_type, and subtype | 1.40e-04 | 199 | 59 | 4 | bf8a10a9db7e8e0a6e2b53747949f442fe0e581e | |
| ToppCell | mLN-Monocyte-Monocyte|mLN / Region, Cell class and subclass | 1.40e-04 | 199 | 59 | 4 | dcee372774c169a3048bdaed3734b3215bf8ffad | |
| ToppCell | COVID-19_Mild-Myeloid|COVID-19_Mild / Disease group, lineage and cell class | 1.40e-04 | 199 | 59 | 4 | d0c230c3699955a80630b63ed18c770444c5dfe5 | |
| ToppCell | Caecum-(6)_Macrophage-(60)_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.42e-04 | 200 | 59 | 4 | 67b6cdeb07ffc5c9af7a3e738dd31256cf391e98 | |
| ToppCell | Transverse-Macrophage-Macrophage|Transverse / Region, Cell class and subclass | 1.42e-04 | 200 | 59 | 4 | 17548806ba38008050244151d1216c69ef8a8310 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.42e-04 | 200 | 59 | 4 | eac46978e2b3d38cf42b44f7b0350d0489d036b3 | |
| ToppCell | Transverse-(6)_Macrophage|Transverse / shred on region, Cell_type, and subtype | 1.42e-04 | 200 | 59 | 4 | b28350de555fa756d2631f004f71d5ac69b1affe | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Sigmoid / Region, Cell class and subclass | 1.42e-04 | 200 | 59 | 4 | 9ee3a799de7bade1bfe94b6827461633f02bc1dc | |
| ToppCell | Caecum-(6)_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.42e-04 | 200 | 59 | 4 | 2ce3930645c3daf6be578f7881e57a58df61e75c | |
| ToppCell | Caecum-Dendritic_cell|Caecum / Region, Cell class and subclass | 1.42e-04 | 200 | 59 | 4 | b91d3d7505a022ca360ab5b3f9955753d111f974 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid|COVID-19_Mild / Disease, condition lineage and cell class | 1.42e-04 | 200 | 59 | 4 | 247040492b3c327f4144fc94cf210dc04eecc7b0 | |
| ToppCell | Transverse-Dendritic_cell|Transverse / Region, Cell class and subclass | 1.42e-04 | 200 | 59 | 4 | b0e9eaf0e57e53645e272e2cea9f09bfcfe12a9b | |
| ToppCell | Caecum-Macrophage|Caecum / Region, Cell class and subclass | 1.42e-04 | 200 | 59 | 4 | d83209559187a4419df2508ecc5eb9f7d72fced3 | |
| ToppCell | control-Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.42e-04 | 200 | 59 | 4 | 251ca08fab5cc2a4e280db6a6286a9ebaef3e61a | |
| ToppCell | Caecum-(5)_Dendritic_cell-(52)_cycling_DCs|Caecum / shred on region, Cell_type, and subtype | 1.42e-04 | 200 | 59 | 4 | 3b04d08e9122c23f42f66bc74c06cf24e1693987 | |
| ToppCell | Caecum-Dendritic_cell-cycling_DCs|Caecum / Region, Cell class and subclass | 1.42e-04 | 200 | 59 | 4 | 608be9bfe74f8d3202aa92b2905452a06f340f76 | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.42e-04 | 200 | 59 | 4 | 8a480f487b52938d00b53bf4b18f067353d34419 | |
| Disease | developmental and epileptic encephalopathy 64 (implicated_via_orthology) | 3.41e-06 | 2 | 55 | 2 | DOID:0070375 (implicated_via_orthology) | |
| Disease | esophageal cancer (is_marker_for) | 2.22e-04 | 12 | 55 | 2 | DOID:5041 (is_marker_for) | |
| Disease | Optic Atrophy, Hereditary, Leber | 3.53e-04 | 15 | 55 | 2 | C0917796 | |
| Disease | Urticaria | 4.03e-04 | 16 | 55 | 2 | C0042109 | |
| Disease | Alcoholic Intoxication, Chronic | 1.58e-03 | 268 | 55 | 4 | C0001973 | |
| Disease | myeloid white cell count | 1.71e-03 | 937 | 55 | 7 | EFO_0007988 | |
| Disease | facial morphology measurement | 1.75e-03 | 466 | 55 | 5 | EFO_0007841 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 1.90e-03 | 131 | 55 | 3 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 1.90e-03 | 131 | 55 | 3 | C4552091 | |
| Disease | Juvenile arthritis | 1.90e-03 | 131 | 55 | 3 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 1.90e-03 | 131 | 55 | 3 | C3714758 | |
| Disease | Juvenile-Onset Still Disease | 2.07e-03 | 135 | 55 | 3 | C0087031 | |
| Disease | vesicoureteral reflux | 2.30e-03 | 38 | 55 | 2 | EFO_0007536 | |
| Disease | systemic lupus erythematosus | 3.63e-03 | 799 | 55 | 6 | MONDO_0007915 | |
| Disease | Behcet's syndrome | 4.42e-03 | 53 | 55 | 2 | EFO_0003780 | |
| Disease | systemic lupus erythematosus, COVID-19 | 5.27e-03 | 58 | 55 | 2 | MONDO_0007915, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RYHGKFTFDTFSHHR | 331 | P48448 | |
| VHAGRQTFHRFDKFN | 376 | Q01432 | |
| SRVGHVFRKRHPYNF | 341 | Q8N428 | |
| TRYKATGLHFRHTDN | 101 | P46940 | |
| RHRFSINGHFYNHKT | 166 | P50749 | |
| RIRRHRFSINGHFYN | 161 | Q9H2L5 | |
| VHRLFHASYGARRDA | 236 | P20702 | |
| SKFIYRHGQIRVFNH | 841 | Q9ULG1 | |
| HFFGKRDIRSRFISH | 586 | Q8WYB5 | |
| YVFASHHFRRRSFRG | 1206 | Q9NRD9 | |
| RISDHHYSKGFRQAA | 51 | P01584 | |
| YKFDRRINFHHGHSL | 71 | Q99665 | |
| DHGKYVESFRRFLNH | 11 | P50135 | |
| KVSVNGQHFLHFRYR | 146 | Q96DT0 | |
| YRKRVQGTHFSRDHL | 346 | Q8TC05 | |
| FGYSKEHGRTAVRHQ | 166 | Q96N21 | |
| YRDQISKYARRFFHH | 566 | O95876 | |
| HYGRFQEFHRKSENT | 381 | Q13325 | |
| SFRYKGNLASHRTVH | 336 | Q8N143 | |
| RDKDFSHQRRHYKEF | 166 | P22003 | |
| SHQRRHYKEFRFDLT | 171 | P22003 | |
| DFGNHNAFRFLRKYR | 256 | P23368 | |
| KRYFGHSAHVTNIRF | 1921 | Q6ZMW3 | |
| YFKDKRVHHFRRSRA | 276 | Q92904 | |
| HLNKDFFRYHASRAR | 431 | O14815 | |
| RHYRNVFHAFITIGK | 41 | Q3KQZ1 | |
| DSRHVAVYHKGRFFK | 331 | Q92523 | |
| KLHFSVYDFDRFSRH | 381 | Q9BQG1 | |
| RQKRLSHVSGHRSYY | 216 | Q9NP81 | |
| DFKEGHVTYHRRFIR | 71 | Q16518 | |
| RFDRGLYASHADLHR | 471 | Q9Y227 | |
| FGDHHKDRRFAYGRS | 86 | Q9BYZ6 | |
| SRHKSHYRNREHFAT | 426 | Q7L7X3 | |
| RRHESKFTDAYNRRH | 311 | Q9UPS6 | |
| FGDHHKDRRFAYGRS | 86 | O94844 | |
| HASQSARFYKHLDRG | 1126 | Q9P2R6 | |
| GDTHFRTFRSHADYR | 51 | O15524 | |
| IHSSRFSGKRHIRYN | 286 | A8MXE2 | |
| THLFHATKQRAYFRN | 61 | Q9Y6N3 | |
| RCGKFFRHRSYLAVH | 611 | Q96IR2 | |
| AYRRRHHNSSLNFFN | 251 | A0A494C1R9 | |
| QSHYFHRDRLNTGSK | 226 | P32780 | |
| AYRRRHHNSSLNFFN | 251 | P0CV99 | |
| RKNSYFVRHQRSHTG | 251 | Q08AN1 | |
| FNRSYNFRLHRRVHT | 456 | Q8TC21 | |
| TFRYGSALKAHQRIH | 646 | Q86YE8 | |
| FTYRSRFFQHQRVHT | 416 | Q9Y2P7 | |
| AFRQSFHHGEYRTHR | 131 | A6NDX5 | |
| SERAEYHGKNHSRTF | 496 | Q6UXZ4 | |
| GKRFAHTSEFNYHRR | 611 | O15060 | |
| RGKAFSYHHSFQSRG | 146 | Q8TA94 | |
| KSFVYGSHLARHRRT | 726 | A6NFI3 | |
| GKVFSYNSHLASHRR | 466 | Q09FC8 | |
| SNLFRHYRIHTGKRS | 281 | Q8IVP9 | |
| YRKTFRHGSQFATHE | 176 | Q969W8 | |
| DVHVARGFSYRKSVH | 231 | Q63HK3 | |
| SFRAHVRDHTGKIQY | 461 | Q32M78 | |
| TLRNHVFFRDRYGAK | 151 | P35125 | |
| QRFRHFQYHEASGPR | 51 | Q9Y2L8 | |
| RFRDKSSYNKHLRAH | 496 | Q9Y3M9 | |
| ERFYRKRRQHSHSYS | 766 | Q7Z570 |